| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 37 | 2022 | 306 | 9.120 |
Why?
|
| Polysaccharides | 25 | 2022 | 176 | 5.630 |
Why?
|
| Extracellular Matrix | 8 | 2021 | 493 | 3.290 |
Why?
|
| Collagen | 7 | 2022 | 636 | 2.960 |
Why?
|
| Protein Processing, Post-Translational | 8 | 2021 | 284 | 2.740 |
Why?
|
| Paraffin Embedding | 7 | 2021 | 47 | 2.500 |
Why?
|
| Tissue Fixation | 6 | 2021 | 58 | 2.430 |
Why?
|
| Aortic Valve | 6 | 2021 | 249 | 2.400 |
Why?
|
| Proteomics | 10 | 2021 | 246 | 2.280 |
Why?
|
| Glycoproteins | 8 | 2022 | 238 | 2.020 |
Why?
|
| Glycomics | 6 | 2021 | 29 | 2.000 |
Why?
|
| Aortic Valve Stenosis | 3 | 2021 | 177 | 1.840 |
Why?
|
| Peptides | 5 | 2021 | 455 | 1.550 |
Why?
|
| Glycosylation | 18 | 2022 | 185 | 1.460 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2022 | 144 | 1.320 |
Why?
|
| Trypsin | 6 | 2018 | 64 | 1.270 |
Why?
|
| Mass Spectrometry | 9 | 2022 | 284 | 1.200 |
Why?
|
| Molecular Imaging | 4 | 2021 | 45 | 1.080 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 211 | 1.040 |
Why?
|
| Histocytochemistry | 3 | 2021 | 149 | 1.020 |
Why?
|
| Lipids | 4 | 2016 | 298 | 0.990 |
Why?
|
| Biomarkers | 6 | 2022 | 1593 | 0.920 |
Why?
|
| Formaldehyde | 6 | 2021 | 48 | 0.920 |
Why?
|
| Isotope Labeling | 4 | 2019 | 30 | 0.720 |
Why?
|
| Prostatic Neoplasms | 3 | 2021 | 778 | 0.720 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 247 | 0.700 |
Why?
|
| Humans | 45 | 2022 | 68525 | 0.650 |
Why?
|
| Animals | 26 | 2022 | 20877 | 0.640 |
Why?
|
| Breast | 1 | 2018 | 137 | 0.630 |
Why?
|
| Proteins | 4 | 2017 | 473 | 0.600 |
Why?
|
| Hydroxylation | 3 | 2021 | 41 | 0.580 |
Why?
|
| Fibroblasts | 1 | 2021 | 902 | 0.560 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 807 | 0.560 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 596 | 0.550 |
Why?
|
| Heart Valves | 1 | 2017 | 171 | 0.530 |
Why?
|
| Biomarkers, Tumor | 4 | 2022 | 508 | 0.480 |
Why?
|
| Workflow | 4 | 2021 | 100 | 0.460 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 334 | 0.430 |
Why?
|
| Chromatography, Liquid | 5 | 2020 | 120 | 0.420 |
Why?
|
| Neuraminidase | 2 | 2022 | 36 | 0.410 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1172 | 0.390 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2020 | 139 | 0.390 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 62 | 0.380 |
Why?
|
| Pulmonary Valve | 1 | 2010 | 40 | 0.380 |
Why?
|
| Tissue Array Analysis | 4 | 2020 | 53 | 0.380 |
Why?
|
| Neoplasms | 1 | 2022 | 1660 | 0.380 |
Why?
|
| Lung Transplantation | 2 | 2021 | 88 | 0.380 |
Why?
|
| Proteome | 4 | 2021 | 87 | 0.380 |
Why?
|
| Elastin | 3 | 2021 | 116 | 0.370 |
Why?
|
| Mice | 14 | 2022 | 8472 | 0.370 |
Why?
|
| Prostate | 2 | 2021 | 116 | 0.370 |
Why?
|
| Proline | 2 | 2020 | 52 | 0.370 |
Why?
|
| Oxygen Isotopes | 2 | 2007 | 7 | 0.370 |
Why?
|
| Tissue Distribution | 2 | 2021 | 282 | 0.350 |
Why?
|
| Liver Cirrhosis | 4 | 2022 | 301 | 0.350 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 4 | 2021 | 67 | 0.340 |
Why?
|
| Immunohistochemistry | 5 | 2021 | 1174 | 0.340 |
Why?
|
| Peptide Fragments | 3 | 2021 | 483 | 0.320 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2021 | 163 | 0.310 |
Why?
|
| Fixatives | 2 | 2021 | 24 | 0.310 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 3 | 2022 | 17 | 0.300 |
Why?
|
| Carbamates | 1 | 2007 | 41 | 0.290 |
Why?
|
| Disease Progression | 2 | 2020 | 1037 | 0.270 |
Why?
|
| Kidney | 2 | 2021 | 945 | 0.270 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 3 | 2022 | 19 | 0.260 |
Why?
|
| Diagnostic Imaging | 2 | 2021 | 201 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 1533 | 0.250 |
Why?
|
| Glycoside Hydrolases | 2 | 2022 | 25 | 0.250 |
Why?
|
| Liver | 4 | 2022 | 1118 | 0.240 |
Why?
|
| Prostatectomy | 2 | 2021 | 87 | 0.230 |
Why?
|
| Female | 11 | 2022 | 38015 | 0.220 |
Why?
|
| Fucose | 2 | 2019 | 25 | 0.220 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 481 | 0.220 |
Why?
|
| Male | 13 | 2022 | 37281 | 0.220 |
Why?
|
| Optic Disk | 1 | 2022 | 37 | 0.210 |
Why?
|
| Research Design | 3 | 2022 | 729 | 0.210 |
Why?
|
| Ocular Hypertension | 1 | 2022 | 43 | 0.210 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2020 | 72 | 0.210 |
Why?
|
| Phosphotransferases (Phosphomutases) | 1 | 2021 | 2 | 0.210 |
Why?
|
| Autoantibodies | 2 | 2021 | 434 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2673 | 0.210 |
Why?
|
| Primary Graft Dysfunction | 1 | 2021 | 12 | 0.210 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 207 | 0.210 |
Why?
|
| Peptide Hydrolases | 1 | 2021 | 82 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2022 | 2550 | 0.200 |
Why?
|
| Phospholipids | 2 | 2013 | 108 | 0.200 |
Why?
|
| Cadherins | 1 | 2021 | 93 | 0.200 |
Why?
|
| Patient Portals | 1 | 2021 | 12 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 86 | 0.200 |
Why?
|
| Microtomy | 1 | 2020 | 11 | 0.200 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2020 | 14 | 0.200 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 87 | 0.190 |
Why?
|
| Lectins | 1 | 2020 | 81 | 0.190 |
Why?
|
| Collagen Type VIII | 1 | 2020 | 7 | 0.190 |
Why?
|
| Non-Fibrillar Collagens | 1 | 2020 | 9 | 0.190 |
Why?
|
| Mesangial Cells | 1 | 2021 | 37 | 0.190 |
Why?
|
| Collagen Type III | 1 | 2020 | 21 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 68 | 0.190 |
Why?
|
| Collagen Type IV | 1 | 2020 | 28 | 0.190 |
Why?
|
| Pathology | 1 | 2020 | 17 | 0.190 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 46 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 2790 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 114 | 0.190 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2020 | 24 | 0.180 |
Why?
|
| Fibrillar Collagens | 1 | 2020 | 49 | 0.180 |
Why?
|
| Brain | 4 | 2016 | 2175 | 0.180 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 38 | 0.180 |
Why?
|
| Autoantigens | 1 | 2020 | 91 | 0.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 175 | 0.180 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 51 | 0.180 |
Why?
|
| Child | 2 | 2021 | 6400 | 0.180 |
Why?
|
| Middle Aged | 5 | 2022 | 21119 | 0.180 |
Why?
|
| Collagen Type I | 1 | 2020 | 175 | 0.180 |
Why?
|
| Research | 1 | 2021 | 214 | 0.180 |
Why?
|
| Area Under Curve | 1 | 2020 | 238 | 0.180 |
Why?
|
| Amino Sugars | 1 | 2019 | 12 | 0.170 |
Why?
|
| Receptors, Purinergic | 1 | 2019 | 10 | 0.170 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 47 | 0.170 |
Why?
|
| Lupus Nephritis | 1 | 2021 | 193 | 0.170 |
Why?
|
| Optical Imaging | 1 | 2019 | 46 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 110 | 0.170 |
Why?
|
| Fibrosis | 1 | 2021 | 371 | 0.170 |
Why?
|
| Breast Diseases | 1 | 2018 | 40 | 0.170 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 186 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 206 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 498 | 0.160 |
Why?
|
| Microscopy | 1 | 2018 | 64 | 0.160 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1082 | 0.160 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2019 | 152 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 307 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2012 | 618 | 0.160 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2018 | 62 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 785 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 332 | 0.150 |
Why?
|
| Animals, Newborn | 2 | 2016 | 396 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 689 | 0.150 |
Why?
|
| Myocardium | 2 | 2021 | 1204 | 0.150 |
Why?
|
| Drug-Seeking Behavior | 1 | 2019 | 213 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2019 | 204 | 0.140 |
Why?
|
| Heart | 1 | 2021 | 850 | 0.140 |
Why?
|
| Colitis | 1 | 2018 | 156 | 0.140 |
Why?
|
| Sheep, Domestic | 1 | 2016 | 5 | 0.140 |
Why?
|
| Hippocampus | 1 | 2019 | 471 | 0.140 |
Why?
|
| Metabolome | 1 | 2016 | 15 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 223 | 0.140 |
Why?
|
| Aged | 4 | 2020 | 14842 | 0.140 |
Why?
|
| Metabolomics | 1 | 2016 | 28 | 0.140 |
Why?
|
| Cattle | 2 | 2007 | 475 | 0.140 |
Why?
|
| Spectrometry, Mass, Secondary Ion | 1 | 2014 | 2 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 70 | 0.130 |
Why?
|
| Infant, Newborn | 1 | 2021 | 2453 | 0.130 |
Why?
|
| Bone Marrow | 1 | 2015 | 168 | 0.130 |
Why?
|
| Cocaine | 1 | 2019 | 555 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 1 | 2019 | 504 | 0.120 |
Why?
|
| Infant | 1 | 2021 | 2891 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 756 | 0.120 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 40 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2021 | 3185 | 0.120 |
Why?
|
| Adult | 4 | 2020 | 21375 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2021 | 1615 | 0.120 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 24 | 0.110 |
Why?
|
| Tongue | 1 | 2013 | 20 | 0.110 |
Why?
|
| Hypertension | 1 | 2022 | 1531 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2013 | 97 | 0.110 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 176 | 0.110 |
Why?
|
| Formates | 1 | 2012 | 2 | 0.110 |
Why?
|
| Ions | 1 | 2012 | 50 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 4843 | 0.100 |
Why?
|
| Acetates | 1 | 2012 | 74 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 32 | 0.100 |
Why?
|
| Detergents | 1 | 2011 | 34 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1860 | 0.100 |
Why?
|
| Isomerism | 2 | 2021 | 63 | 0.100 |
Why?
|
| Mitochondria | 1 | 2016 | 643 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 563 | 0.100 |
Why?
|
| Surface-Active Agents | 1 | 2011 | 57 | 0.090 |
Why?
|
| Algorithms | 1 | 2016 | 1194 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 261 | 0.090 |
Why?
|
| Polygalacturonase | 1 | 2009 | 2 | 0.090 |
Why?
|
| Pyrus | 1 | 2009 | 2 | 0.090 |
Why?
|
| Plant Proteins | 1 | 2009 | 48 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2019 | 1692 | 0.080 |
Why?
|
| Adolescent | 1 | 2021 | 8903 | 0.080 |
Why?
|
| Lung | 1 | 2013 | 849 | 0.080 |
Why?
|
| Young Adult | 1 | 2018 | 5708 | 0.080 |
Why?
|
| Cytokines | 2 | 2022 | 866 | 0.080 |
Why?
|
| Caseins | 1 | 2007 | 19 | 0.070 |
Why?
|
| Asparagine | 1 | 2007 | 15 | 0.070 |
Why?
|
| alpha-Fetoproteins | 1 | 2007 | 22 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2021 | 2688 | 0.070 |
Why?
|
| Peptide Mapping | 1 | 2007 | 39 | 0.070 |
Why?
|
| Indicators and Reagents | 1 | 2007 | 63 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 43 | 0.070 |
Why?
|
| Calibration | 1 | 2007 | 73 | 0.070 |
Why?
|
| Hydrolysis | 1 | 2007 | 144 | 0.070 |
Why?
|
| Reference Standards | 1 | 2007 | 115 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2011 | 617 | 0.070 |
Why?
|
| Aspartic Acid | 1 | 2007 | 65 | 0.070 |
Why?
|
| Carbohydrate Conformation | 2 | 2021 | 25 | 0.070 |
Why?
|
| Transferrin | 1 | 2007 | 94 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 381 | 0.070 |
Why?
|
| Water | 1 | 2006 | 228 | 0.070 |
Why?
|
| Oxygen | 1 | 2006 | 386 | 0.060 |
Why?
|
| Sialic Acids | 1 | 2022 | 27 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2022 | 106 | 0.050 |
Why?
|
| Diet, Western | 1 | 2022 | 17 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1753 | 0.050 |
Why?
|
| Lasers | 1 | 2021 | 61 | 0.050 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2021 | 15 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2021 | 35 | 0.050 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2021 | 80 | 0.050 |
Why?
|
| Serum | 1 | 2021 | 24 | 0.050 |
Why?
|
| Ischemia | 1 | 2022 | 229 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 242 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2021 | 118 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 183 | 0.050 |
Why?
|
| Chemistry, Clinical | 1 | 2020 | 6 | 0.050 |
Why?
|
| Microbiological Techniques | 1 | 2020 | 9 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2021 | 234 | 0.050 |
Why?
|
| Retina | 1 | 2022 | 252 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 110 | 0.050 |
Why?
|
| Fucosyltransferases | 1 | 2020 | 6 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2020 | 132 | 0.050 |
Why?
|
| Liquid Biopsy | 1 | 2019 | 6 | 0.050 |
Why?
|
| Mammography | 1 | 2022 | 310 | 0.050 |
Why?
|
| Methods | 1 | 2019 | 156 | 0.040 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2020 | 39 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2020 | 107 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2021 | 175 | 0.040 |
Why?
|
| Pancreas | 1 | 2020 | 225 | 0.040 |
Why?
|
| Carbohydrate Sequence | 2 | 2009 | 45 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2019 | 62 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2022 | 866 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 277 | 0.040 |
Why?
|
| Antibodies | 1 | 2019 | 241 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 179 | 0.040 |
Why?
|
| Ceramides | 1 | 2022 | 578 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 306 | 0.040 |
Why?
|
| Aorta | 1 | 2019 | 316 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 532 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 258 | 0.040 |
Why?
|
| Self Administration | 1 | 2019 | 419 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2019 | 240 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2018 | 88 | 0.040 |
Why?
|
| Conditioning, Operant | 1 | 2019 | 241 | 0.040 |
Why?
|
| Disease Management | 1 | 2019 | 248 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2019 | 209 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 539 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 714 | 0.040 |
Why?
|
| Rats | 2 | 2019 | 5300 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 536 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 1446 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2019 | 384 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2016 | 15 | 0.030 |
Why?
|
| Behavior, Addictive | 1 | 2019 | 317 | 0.030 |
Why?
|
| Autopsy | 1 | 2016 | 56 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 65 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1030 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 147 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 756 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 718 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1548 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1293 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2077 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 93 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 2083 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1849 | 0.030 |
Why?
|
| Thymosin | 1 | 2013 | 1 | 0.030 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2013 | 38 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 57 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 946 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2013 | 146 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 142 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 492 | 0.030 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2011 | 2 | 0.030 |
Why?
|
| Chromosome Duplication | 1 | 2011 | 2 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2013 | 206 | 0.030 |
Why?
|
| Karyotyping | 1 | 2011 | 74 | 0.030 |
Why?
|
| Polysorbates | 1 | 2011 | 1 | 0.020 |
Why?
|
| Cholic Acids | 1 | 2011 | 8 | 0.020 |
Why?
|
| Octoxynol | 1 | 2011 | 19 | 0.020 |
Why?
|
| Trisomy | 1 | 2011 | 47 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2011 | 11 | 0.020 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2011 | 24 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 272 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 48 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2010 | 44 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 189 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2011 | 173 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2222 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 489 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2009 | 13 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2009 | 31 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 770 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2009 | 108 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2009 | 362 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 1752 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 546 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1034 | 0.020 |
Why?
|